You are here

Algernon Pharmaceuticals Inc. - Warrants

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
AGN.WT
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

Algernon Pharmaceuticals Inc. - Common Shares

You are here

Algernon Pharmaceuticals Inc. - Warrants (AGN.WT)

SEDAR Information

Company Info

Address
Suite 900 - 700 West Pender Street
Vancouver, BC V6C 1G8
Canada
Phone
604-398-4175
Ext
701
Email
chris@algernonpharmaceuticals.com
Website
https://algernonpharmaceuticals.com
Listing date
Monday, November 4, 2019
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
24,401,300
Reserved for Issuance: 
0

News Releases

CSE Filings

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-12-09-Nation-Builder-of-the-Year-Award-2021_Website.jpg

2021 Nation Builder of the Year Award

Thursday, December 9, 2021 -
12:00pm to 1:00pm
JM_DigitalBanners_VRIC_Website.jpg

Vancouver Resource Investment Conference (VRIC)

Sunday, January 16, 2022 - 8:30am to Monday, January 17, 2022 - 5:30pm
Can-Securities-Exchange_PDAC22_web-740x374_Website.jpg

90th Annual PDAC Convention 2022

Monday, March 7, 2022 to Friday, March 11, 2022